Rising Prevalence Of Chronic Pain To Drive Market Growth: Strengthening the Growth Trajectory of the Non-Steroidal Anti-inflammatory Drugs Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Non-Steroidal Anti-inflammatory Drugs Market Through 2025?
The market size for non-steroidal anti-inflammatory drugs has seen significant growth in the recent past. It is projected to expand from a value of $20.68 billion in 2024 to an approximately $21.89 billion in 2025, signaling a compound annual growth rate (CAGR) of 5.8%. This substantial growth during the historical period can be linked to various factors. These include the prevalence of chronic inflammatory diseases, management of post-surgery pain, sports-related injuries, availability of these drugs over-the-counter, an aging population, and increased consumer awareness.

What's the Projected Size of the Global Non-Steroidal Anti-inflammatory Drugs Market by 2029?
Expectations are high for robust growth in the non-steroidal anti-inflammatory drugs market in the upcoming years, with the market predicted to reach $28.15 billion by 2029, expanding at a compound annual growth rate (CAGR) of 6.5%. Several factors contributing to this projected growth during the forecast period include the advent of novel pain management therapies, regulatory modifications, the rise of telehealth, global health trends, increased competition from biosimilars, changes in patient preferences, and the adoption of precision medicine strategies. The forecast period also anticipates significant trends such as the dominance of the over-the-counter (OTC) market, greater interest in cox-2 inhibitors, increased generic and market competition, and the effective incorporation of digital health technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report

Top Growth Drivers in the Non-Steroidal Anti-inflammatory Drugs Industry: What's Accelerating the Market?
The increasing cases of enduring pain are predicted to boost the expansion of the non-steroidal anti-inflammatory drugs market in the near future. Chronic pain is a discomfort that lasts beyond six months. Non-steroidal anti-inflammatory medications are utilized to mend injuries and manage persistent pain. For example, a report from the CDC (Centers for Disease Control and Prevention), a government agency in the USA, stated in April 2022 that arthritis was a common cause of chronic pain impacting millions in the country. Roughly one in four adults suffering from arthritis, which equates to around 15 million people, are dealing with intense joint pain due to this condition. Hence, the rising prevalence of chronic pain is contributing significantly to the growth of the non-steroidal anti-inflammatory drugs market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8023&type=smp

What Long-Term Trends Will Define the Future of the Non-Steroidal Anti-inflammatory Drugs Market?
A primary trend in the non-steroidal anti-inflammatory drugs market is the focus on product innovation. Major players in this market are primarily focusing on the development of new technological solutions. For example, in March 2024, an Irish pharmaceutical organization, Endo International plc, introduced tablets consisting of ibuprofen-famotidine 800 mg/26.6 mg. These tablets are a blend of ibuprofen's analgesic and anti-inflammatory abilities along with famotidine's protective effects on the stomach. The formulation is aimed at easing pain and reducing the likelihood of gastrointestinal issues that could arise from prolonged use of nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen.

What Are the Main Segments in the Non-Steroidal Anti-inflammatory Drugs Market?
The non-steroidal anti-inflammatory drugs market covered in this report is segmented -

1) By Route Of Administration: Oral, Topical, Other Route Of Administration
2) By Disease Indication: Arthritis, Migraine, Ophthalmic Diseases, Other Disease Indications
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:
1) By Oral: Tablets, Capsules, Liquids Or Solutions
2) By Topical: Gels, Creams, Patches
3) By Other Route Of Administration: Injectable (Intravenous And Intramuscular), Suppositories

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8023&type=smp

Which Top Companies are Driving Growth in the Non-Steroidal Anti-inflammatory Drugs Market?
Major companies operating in the non-steroidal anti-inflammatory drugs market are Pfizer Inc., Bayer AG, Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Assertio Therapeutics Inc., Iroko Pharmaceuticals Inc., Reckitt Benckiser Group PLC, Perrigo Company PLC, Hikma Pharmaceuticals Public Limited Company, Glenmark Pharmaceuticals Limited, Septodont, Aspen Pharmacare Holdings Limited, Sagent Pharmaceuticals Inc., Advanced Pharma Inc., Akorn Operating Company LLC, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Lupin Limited, Cipla Limited, Zydus Cadila Healthcare Limited, Aurobindo Pharma Limited, Sanofi S.A., GlaxoSmithKline PLC, Horizon Therapeutics PLC, Zyla Life sciences, Novartis AG, Roche Holding AG, AbbVie Inc., Bristol-Myers Squibb Company

Which Regions Will Dominate the Non-Steroidal Anti-inflammatory Drugs Market Through 2029?
North America was the largest region in the non-steroidal anti-inflammatory drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the non-steroidal anti-inflammatory drugs market during the forecast period. The regions covered in the non-steroidal anti-inflammatory drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8023

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.